Terms: = Breast cancer AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E AND Prognosis
21 results:
1. [Clinical characteristics and prognosis of patients with therapy-related myelodysplastic syndrome and acute myeloid leukemia arising from malignant tumors].
Xu XS; Ding H; Zhang X; Liao Y; Li H; Liu QY; Liu JZ; Zhang L; Huang J; Gong YP; Ma HB; Xiang B; Dai Y; Hou L; Shuai X; Niu T; Wu Y
Zhonghua Xue Ye Xue Za Zhi; 2023 Sep; 44(9):742-748. PubMed ID: 38049318
[No Abstract] [Full Text] [Related]
2. Clinician perspectives on patient-centered conversations about weight management with patients with early breast cancer.
Nyrop KA; Kelly EA; Teal R; Muss HB; Charlot M
Cancer; 2023 Sep; 129(S19):3128-3140. PubMed ID: 37691525
[TBL] [Abstract] [Full Text] [Related]
3. Therapy-related myeloid neoplasm in early breast cancer patients treated with adjuvant chemotherapy.
Lee JW; Oh H; You JY; Lee ES; Lee JH; Song SE; Lee NK; Jung SP; An JS; Cho KR; Kim CY; Park KH
Eur J Cancer; 2023 Sep; 191():112952. PubMed ID: 37473463
[TBL] [Abstract] [Full Text] [Related]
4. breast metastasis in high-grade endometrial stromal sarcoma (HG-ESS) with BCOR rearrangement: a case report of a novel metastatic site.
Fong A; Offman S
Diagn Pathol; 2023 Mar; 18(1):34. PubMed ID: 36864468
[TBL] [Abstract] [Full Text] [Related]
5. Studying the connection between SF3B1 and four types of cancer by analyzing networks constructed based on published research.
Samy A; Ozdemir MK; Alhajj R
Sci Rep; 2023 Feb; 13(1):2704. PubMed ID: 36792691
[TBL] [Abstract] [Full Text] [Related]
6. B-cell acute lymphoblastic leukemia in an elderly man with plasma cell myeloma and long-term exposure to thalidomide and lenalidomide: a case report and literature review.
Sinit RB; Hwang DG; Vishnu P; Peterson JF; Aboulafia DM
BMC Cancer; 2019 Nov; 19(1):1147. PubMed ID: 31775673
[TBL] [Abstract] [Full Text] [Related]
7. In silico analysis of nsSNPs in ABCB1 gene affecting breast cancer associated protein P-glycoprotein (P-gp).
Chakraborty R; Gupta H; Rahman R; Hasija Y
Comput Biol Chem; 2018 Dec; 77():430-441. PubMed ID: 30181081
[TBL] [Abstract] [Full Text] [Related]
8. Large-scale gene network analysis reveals the significance of extracellular matrix pathway and homeobox genes in acute myeloid leukemia: an introduction to the Pigengene package and its applications.
Foroushani A; Agrahari R; Docking R; Chang L; Duns G; Hudoba M; Karsan A; Zare H
BMC Med Genomics; 2017 Mar; 10(1):16. PubMed ID: 28298217
[TBL] [Abstract] [Full Text] [Related]
9. Therapy-related myelodysplastic syndrome following primary breast cancer.
Malmgren JA; Calip GS; Pyott SM; Atwood MK; Kaplan HG
Leuk Res; 2016 Aug; 47():178-84. PubMed ID: 27414978
[TBL] [Abstract] [Full Text] [Related]
10. Immunoproteomics of HER2-positive and HER2-negative breast cancer patients with positive lymph nodes.
Mojtahedi Z; Safaei A; Yousefi Z; Ghaderi A
OMICS; 2011 Jun; 15(6):409-18. PubMed ID: 21568730
[TBL] [Abstract] [Full Text] [Related]
11. Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study.
Moebus V; Jackisch C; Lueck HJ; du Bois A; Thomssen C; Kurbacher C; Kuhn W; Nitz U; Schneeweiss A; Huober J; Harbeck N; von Minckwitz G; Runnebaum IB; Hinke A; Kreienberg R; Konecny GE; Untch M
J Clin Oncol; 2010 Jun; 28(17):2874-80. PubMed ID: 20458045
[TBL] [Abstract] [Full Text] [Related]
12. Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training.
Turner RR; Weaver DL; Cserni G; Lester SC; Hirsch K; Elashoff DA; Fitzgibbons PL; Viale G; Mazzarol G; Ibarra JA; Schnitt SJ; Giuliano AE
J Clin Oncol; 2008 Jan; 26(2):258-63. PubMed ID: 18182666
[TBL] [Abstract] [Full Text] [Related]
13. Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs.
Chuthapisith S; Layfield R; Kerr ID; Hughes C; Eremin O
Int J Oncol; 2007 Jun; 30(6):1545-51. PubMed ID: 17487377
[TBL] [Abstract] [Full Text] [Related]
14. Use of high-throughput protein array for profiling of differentially expressed proteins in normal and malignant breast tissue.
Hudelist G; Pacher-Zavisin M; Singer CF; Holper T; Kubista E; Schreiber M; Manavi M; Bilban M; Czerwenka K
Breast Cancer Res Treat; 2004 Aug; 86(3):281-91. PubMed ID: 15567944
[TBL] [Abstract] [Full Text] [Related]
15. Modulation of drug resistance transporters as a strategy for treating myelodysplastic syndrome.
Ross DD
Best Pract Res Clin Haematol; 2004 Dec; 17(4):641-51. PubMed ID: 15494300
[TBL] [Abstract] [Full Text] [Related]
16. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract] [Full Text] [Related]
17. Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma.
Berglund A; Enblad G; Carlson K; Glimelius B; Hagberg H
Eur J Haematol; 2000 Jul; 65(1):17-22. PubMed ID: 10914935
[TBL] [Abstract] [Full Text] [Related]
18. The incidence of secondary leukemias.
Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
[TBL] [Abstract] [Full Text] [Related]
19. Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype.
Ben-Yehuda D; Krichevsky S; Caspi O; Rund D; Polliack A; Abeliovich D; Zelig O; Yahalom V; Paltiel O; Or R; Peretz T; Ben-Neriah S; Yehuda O; Rachmilewitz EA
Blood; 1996 Dec; 88(11):4296-303. PubMed ID: 8943866
[TBL] [Abstract] [Full Text] [Related]
20. Risk of acute myelogenous leukaemia and myelodysplasia following cancer treatment.
van Leeuwen FE
Baillieres Clin Haematol; 1996 Mar; 9(1):57-85. PubMed ID: 8730551
[TBL] [Abstract] [Full Text] [Related]
[Next]
